As obesity drug developers compete for the highest weight-loss efficacy, experts contend that overall health ...

While drug developers work to mitigate the side effects associated with GLP-1–based obesity drugs, recent studies reveal that ...

In a letter (PDF) to shareholders, executives said the company has a legal pathway to sell "personalized titration schedules ... also offers subscriptions for Wegovy and Ozempic, starting around ...

Wegovy Important Safety Information ... Ozempic follows a dose titration schedule, where people start at a low 0.25 mg dosage and ramp up to their final maintenance dosage over 12–16 weeks.

Ozempic, along with its sister drug Wegovy, belongs to a new class of ... Typically, a responsible doctor approaches prescriptions with a titration mindset: starting at a low dose and slowly ...